Nuclear medicine and biologyMaleCopper RadioisotopesProstatic NeoplasmsHumansGlutamate Carboxypeptidase II
Preclinical evaluation and dosimetry of [64Cu/67Cu]Cu-NGUL for PSMA-targeted prostate cancer theranostics.
Hye Yeon Seo, Minseok Suh, Nadeem Ahmed Lodhi, Ran Ji Yoo, Young Joo Kim, Ji Yong Park, Azmal Kabir Sarker, Kyo Chul Lee, Yong Jin Lee, Gwangil An, Kweon Kim, Jae Min Jeong, Yun-Sang Lee
Published: 202510.1016/j.nucmedbio.2025.109569
Abstract
BACKGROUND: Prostate-specific membrane antigen (PSMA) is a promising target for imaging and theranostics in prostate cancer (PCa). Current PSMA tracers face limitations due to short half-lives and logistics. We developed a PSMA-targeted PET radiotrac…
Preview only. Read the full abstract at the source